• NICE Technology Appraisal of implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure.

  ICDs and CRTs are recommended as a treatment options. The guidance defines the patient groups.

• NICE Technology Appraisal of dual‑chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome without atrioventricular block.

  Dual-chamber pacemakers are recommended as a treatment option.

• Guidance from NICE: Interventional Procedures Guidance (IPG 711) on percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure.

  This guidance recommends standard arrangements are in place for clinical governance, consent, and audit on pulmonary artery pressure sensors for monitoring treatment of chronic heart failure.

• Publication of cost-effectiveness of HeartMate 3 vs. medical therapy in transplant-ineligible patients

  This peer-reviewed manuscript supports HeartMate 3™ LVAD in destination therapy as a cost-effective option vs. medical therapy in the UK for advanced heart failure patients ineligible for transplant.

National Institute for Health and Care Excellence (NICE)

• NICE Interventional Procedures Guidance on percutaneous mitral valve leaflet repair for mitral regurgitation.

  These recommendations include standard arrangements for clinical governance, consent and audit or research in the procedure of percutaneous mitral valve leaflet repair for mitral regurgitation.

• NICE Interventional Procedures Guidance on percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism.

  These recommendations include normal arrangements for clinical governance, consent and audit or research in the procedure of percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism.

• NICE Interventional Procedures Guidance on percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events.

  These recommendations include normal arrangements for clinical governance, consent and audit or research in the procedure of percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events.

• Commissioning policy for percutaneous patent foraman ovale closure for the prevention of recurrent cerebral embolic stroke in adults (around the age 60 years and under).

  Routinely commissioned by NHS England Specialised Services

• Commissioning policy for percutaneous mitral valve leaflet repair for primary degenerative mitral regurgitation in adults.

  Routinely commissioned by NHS England Specialised Services

• Commissioning policy for Left Atrial Appendage Occlusion for patients with atrial fibrillation and relative or absolute contraindications to anticoagulation (adults).

  Routinely commissioned by NHS England Specialised Services

• Commissioning policy for Transcatheter Aortic Valve Implantation (TAVI) For Aortic Stenosis.

  Routinely commissioned by NHS England Specialised Services

• NICE Interventional Procedures Guidance on Optical Coherence Tomography (OCT).

  These recommendations include special arrangements for clinical governance, consent and audit or research in OCT use.

• NICE Interventional Procedure Guidance on percutaneous mechanical thrombectomy for acute deep vein thrombosis of the leg

  The recommendations include:

  For acute iliofemoral DVT, the evidence on efficacy is limited in quality and quantity, therefore this procedure should only be used with special arrangements for clinical governance, consent, and audit or research.

  For distal DVT that does not extend into the common femoral vein, the evidence on efficacy is inconclusive, therefore this procedure should only be used in the context of research.

  These recommendations include special arrangements for clinical governance, consent and audit or research in the procedure of percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventions.